ClinConnect ClinConnect Logo
Search / Trial NCT06766721

Ultrasound for Diagnosing Costochondral Joint Separation

Launched by CANER İŞEVI, MD · Jan 5, 2025

Trial Information

Current as of July 04, 2025

Not yet recruiting

Keywords

Costochondral Joint Separation Ultrasound Blunt Thoracic Trauma Thoracic Surgery Computed Tomography

ClinConnect Summary

This clinical trial is studying how well ultrasound can detect costochondral joint separation, which is an injury that can happen in the chest area, especially after a hard hit to the body, like in car accidents or falls. Researchers will compare the results from the ultrasound with those from a CT scan, a type of imaging test, to see how accurately ultrasound can identify this kind of injury. The goal is to improve the way doctors diagnose these injuries while reducing the amount of radiation patients are exposed to from CT scans.

To participate in this trial, patients need to be between 18 and 80 years old and have experienced blunt trauma to the chest with a suspicion of costochondral joint separation. Those who cannot have a CT scan, are pregnant, or have certain medical conditions that might interfere with the ultrasound cannot take part. If eligible, participants can expect to undergo both an ultrasound and a CT scan, and they will be asked to give their consent before starting the process. This study is being conducted at Ondokuz Mayıs University Faculty of Medicine, and it is not yet open for recruitment.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 18 to 80 years
  • Patients with blunt thoracic trauma
  • Patients suspected of having costochondral joint separation
  • Patients who provide consent for ultrasound and CT imaging
  • Exclusion Criteria:
  • Patients under 18 or over 80 years of age
  • Patients with penetrating thoracic trauma
  • Patients with subcutaneous emphysema that prevents ultrasound evaluation
  • Patients allergic to ultrasound gel
  • Pregnant patients (as CT imaging is contraindicated)
  • Patients unable to undergo CT imaging
  • Patients who refuse to participate in the study
  • Obese patients (body mass index \>30), as ultrasound evaluation may be challenging

About Caner İşevi, Md

Caner İşevi, MD, is a distinguished clinical trial sponsor dedicated to advancing medical research and innovation. With a focus on improving patient outcomes, Dr. İşevi leads a team committed to conducting rigorous and ethical clinical trials across various therapeutic areas. Their expertise in clinical study design and implementation, combined with a patient-centered approach, ensures that research initiatives are both scientifically robust and aligned with the highest standards of care. As a trusted partner in the clinical research community, Caner İşevi, MD, is dedicated to translating scientific discoveries into effective treatments for patients.

Locations

Samsun, , Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported